Calgary biotechnology startup NanoTess is bringing its made-in-Calgary wound care technology to the chutes at this year’s Calgary Stampede.
The company’s NanoSALV Catalytic product will be used by the Canadian Pro Rodeo Sport Medicine team to support rodeo athletes dealing with friction burns, skin abrasions, blisters, puncture wounds, lacerations, sutured injuries, and surgical incisions.
Powered by NanoTess’ proprietary catalytic technology, CTM, NanoSALV Catalytic is used by physicians, surgeons, paramedics, and patients across Canada to support the healing of acute, traumatic, chronic, and complex wounds.
Megan Leslie, co-founder and CEO of NanoTess, said the product is well suited to the demands of rodeo.
PRESENTED BY
“Everyone knows that rodeo competitors are the toughest athletes in the world, but even the toughest athletes need wound care when things go sideways,” said Leslie. “Whether it’s a deep tissue rope burn or a laceration from a fall, we know nothing means more to them than getting back out there as quickly as possible.”
“As a Calgary-based company, we’re thrilled to be able to support competitors in this year’s Calgary Stampede, with our advanced wound care technology that’s made right here in the city,” she added.
Canadian Pro Rodeo Sport Medicine provides medical coverage at rodeos across Canada for more than 275 days each year. Its team of 70 caregivers includes athletic therapists, massage therapists, and chiropractors.
Brandon Thome, the organization’s executive director, said the team manages a wide range of wounds throughout the rodeo season, from blisters and rope burns to puncture wounds, cuts, scrapes, and abrasions.
“Having a simple, effective wound care product that our practitioners can confidently apply across this broad spectrum of injuries has the potential to enhance the care we provide to athletes,” said Thome. “It’s especially rewarding to support an innovative solution developed in Calgary.”
NanoSALV Catalytic is a medical device authorized for sale by Health Canada and is used by healthcare systems across Canada.
According to NanoTess, CTM uses micron-scale catalysts that work on the surface of injured tissue, leveraging copper to support regenerative signalling, modulate inflammation, and provide broad-spectrum antimicrobial and antiviral action.
The product is also covered through Alberta’s public health benefits programs, including Coverage for Seniors, Non-Group Coverage, Palliative, and AISH.
Leave a Reply